Gabriella Giancane
Overview
Explore the profile of Gabriella Giancane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Giancane G, Rosina S, Consolaro A, Ruperto N
Curr Rheumatol Rep
. 2021 Mar;
23(4):23.
PMID: 33683471
Purpose Of Review: Providing a summary of the latest research on outcome measures in juvenile idiopathic arthritis, childhood -onset systemic lupus erythematosus, and juvenile dermatomyositis. Recent Findings: A rational management...
12.
van Straalen J, Giancane G, Amazrhar Y, Tzaribachev N, Lazar C, Uziel Y, et al.
Rheumatology (Oxford)
. 2020 Dec;
60(6):2896-2905.
PMID: 33274366
Objective: To build a prediction model for uveitis in children with JIA for use in current clinical practice. Methods: Data from the international observational Pharmachild registry were used. Adjusted risk...
13.
Giancane G, Campone C, Gicchino M, Alongi A, Bava C, Rosina S, et al.
Arthritis Care Res (Hoboken)
. 2020 Nov;
73(12):1722-1729.
PMID: 33242352
Objective: To assess concordance among criteria for inactive disease (ID) and low disease activity (LDA) in juvenile idiopathic arthritis (JIA) and to seek factors driving discordance. Methods: The frequency of...
14.
Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalpra S, et al.
Clin Exp Rheumatol
. 2020 Nov;
39(2):426-433.
PMID: 33200734
Objectives: To investigate the frequency of arthritis flare and factors affecting occurrence of flare in children with juvenile idiopathic arthritis (JIA) who achieved inactive disease (ID) with methotrexate (MTX) monotherapy....
15.
Malattia C, Ruperto N, Pederzoli S, Palmisani E, Pistorio A, Wouters C, et al.
Arthritis Res Ther
. 2020 Sep;
22(1):211.
PMID: 32912276
Background: Few clinical trials have investigated the prevention of radiographic progression in children with juvenile idiopathic arthritis treated with antirheumatic drugs. This study aimed to investigate radiographic progression in patients...
16.
Tibaldi J, Pistorio A, Aldera E, Puzone L, Miedany Y, Pal P, et al.
Rheumatology (Oxford)
. 2020 Aug;
59(11):3505-3514.
PMID: 32829413
Objective: To develop a composite disease activity score for systemic JIA (sJIA) and to provide preliminary evidence of its validity. Methods: The systemic Juvenile Arthritis Disease Activity Score (sJADAS) was...
17.
Giancane G, Swart J, Castagnola E, Groll A, Horneff G, Huppertz H, et al.
Arthritis Res Ther
. 2020 Apr;
22(1):71.
PMID: 32264969
Background: To derive a list of opportunistic infections (OI) through the analysis of the juvenile idiopathic arthritis (JIA) patients in the Pharmachild registry by an independent Safety Adjudication Committee (SAC)....
18.
Allegra M, Gicchino M, Giancane G, Alongi A, Tibaldi J, Mazzoni M, et al.
J Rheumatol
. 2019 Nov;
47(8):1238-1241.
PMID: 31676696
Objective: To investigate the effect of morning stiffness (MS) on parent disease perception in children with juvenile idiopathic arthritis (JIA) with clinically inactive disease (CID). Methods: We examined 652 visits...
19.
Nordal E, Pistorio A, Rygg M, Giancane G, Maghnie M, Di Iorgi N, et al.
Arthritis Care Res (Hoboken)
. 2019 Sep;
72(2):265-273.
PMID: 31507092
Objective: To study growth and puberty in a multinational longitudinal prospective cohort of children with juvenile dermatomyositis (DM). Methods: Children from 31 countries who were ages <18 years and had...
20.
Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalpra S, et al.
Pediatr Rheumatol Online J
. 2019 Jul;
17(1):50.
PMID: 31345226
Background: To investigate the frequency of achievement of inactive disease (ID) in children with juvenile idiopathic arthritis (JIA) treated with methotrexate (MTX) as the sole disease-modifyng antirheumatic (DMARD) therapy and...